Bulletin
Investor Alert

BioLife Solutions Inc.

NAS: BLFS

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Aug 5, 2022, 5:38 p.m.

/zigman2/quotes/207858501/composite

$

21.12

Change

-0.37 -1.72%

Volume

Volume 6,049

Quotes are delayed by 20 min

/zigman2/quotes/207858501/composite

Previous close

$ 21.36

$ 21.49

Change

+0.13 +0.61%

Day low

Day high

$20.52

$21.62

Open

52 week low

52 week high

$10.40

$60.67

Open

Annual Financials for BioLife Solutions Inc.

Fiscal year is January-December. All values USD millions. 20172018201920202021 5-year trend
Sales/Revenue 11.02M19.74M27.37M48.09M119.16M
Cost of Goods Sold (COGS) incl. D&A 4.28M6.22M9.84M23.68M90.31M
COGS excluding D&A 3.94M5.88M7.53M17.87M75.26M
Depreciation & Amortization Expense 339,000338,0002.31M5.81M15.06M
Depreciation 339,000338,0001.23M2.77M6.85M
Amortization of Intangibles --1.08M3.03M8.2M
Gross Income 6.75M13.53M17.53M24.41M28.85M
20172018201920202021 5-year trend
SG&A Expense 7.8M9.86M16.76M27.74M58.28M
Research & Development 1.19M1.3M3.17M6.72M11.82M
Other SG&A 6.61M8.57M13.59M21.02M-
Other Operating Expense -----
Unusual Expense -28.27M3.72M(2.68M)(1.82M)
EBIT after Unusual Expense -(28.27M)(2.95M)(655,000)(27.61M)
Non Operating Income/Expense --(13,000)-289,000
Non-Operating Interest Income 1,000281,000506,00058,000-
Equity in Affiliates (Pretax) (1.01M)(672,000)(739,000)--
Interest Expense 455,0005,0005,000-432,000
Gross Interest Expense 455,0005,0005,000-432,000
Interest Capitalized -----
Pretax Income (2.52M)(25.01M)(3.2M)(597,000)(27.75M)
Income Tax --(1.54M)(3.26M)(20.12M)
Income Tax - Current Domestic ---33,000-
Income Tax - Current Foreign ----9,000
Income Tax - Deferred Domestic --(1.54M)(3.3M)(20.13M)
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (2.52M)(25.01M)(1.66M)2.67M(7.64M)
Minority Interest Expense -----
Net Income (2.52M)(25.01M)(1.66M)2.67M(7.64M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (2.52M)(25.01M)(1.66M)2.67M(7.64M)
Preferred Dividends 213,000339,000-217,000-
Net Income Available to Common (2.73M)(25.34M)(1.66M)2.45M(7.64M)
EPS (Basic) (0.21)(1.56)(0.09)0.09(0.20)
Basic Shares Outstanding 13.26M16.26M19.46M27.31M38.5M
EPS (Diluted) (0.21)(1.56)(0.09)(0.03)(0.20)
Diluted Shares Outstanding 13.26M16.26M19.46M27.31M38.5M
EBITDA (717,000)4M3.08M2.47M(14.37M)
Link to MarketWatch's Slice.